BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bohra A, Worland T, Hui S, Terbah R, Farrell A, Robertson M. Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care. World J Gastroenterol 2020; 26(18): 2221-2231 [PMID: 32476788 DOI: 10.3748/wjg.v26.i18.2221]
URL: https://www.wjgnet.com/1948-5182/full/v26/i18/2221.htm
Number Citing Articles
1
Chien-Hao Huang, Hsiao-Jung Tseng, Piero Amodio, Yu-Ling Chen, Sheng-Fu Wang, Shang-Hung Chang, Sen-Yung Hsieh, Chun-Yen Lin. Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis Improve Cirrhosis Outcome Prediction: A Modified Seven-Stage Model as a Clinical Alternative to MELDJournal of Personalized Medicine 2020; 10(4): 186 doi: 10.3390/jpm10040186
2
William S.A. Brusilow. Saul Brusilow: Understanding and treating diseases of ammonia toxicityAnalytical Biochemistry 2022; 636: 114478 doi: 10.1016/j.ab.2021.114478
3
Aalam Sohal, Victoria Green, Sunny Sandhu, Marina Roytman. Identifying areas of improvement in nursing knowledge regarding hepatic encephalopathy managementJournal of Community Hospital Internal Medicine Perspectives 2021; 11(5): 722 doi: 10.1080/20009666.2021.1954784
4
Hong Yang, Jing Tian, Bingxia Meng, Ke Wang, Chu Zheng, Yanling Liu, Jingjing Yan, Qinghua Han, Yanbo Zhang. Application of Extreme Learning Machine in the Survival Analysis of Chronic Heart Failure Patients With High Percentage of Censored Survival TimeFrontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.726516
5
Amera Elzubeir, Syed Munawer Alam. Letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with Rifaxamin’World Journal of Gastroenterology 2020; 26(44): 7085-7087 doi: 10.3748/wjg.v26.i44.7085
6
Yizhen Tian, Weihu Yang, Ruiying Yang, Qingqing Zhang, Luyang Hao, Enze Bian, Yuquan Yang, Xuewei Huang, Yongjie Wu, Baolai Zhang. Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5Toxicology and Applied Pharmacology 2022; 435: 115829 doi: 10.1016/j.taap.2021.115829
7
Juntao Tan, Yuxin He, Zhanbiao Li, Qinghua Zhang, Yanzhi Yang, Qian Xu, Xiaomei Xu. Analysis of the Dose-Response Relationship Between the International Normalized Ratio and Hepatic Encephalopathy in Patients With Liver Cirrhosis Using Restricted Cubic Spline FunctionsFrontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.919549
8
Robert S. Rahimi, Kimberly A. Brown, Steven L. Flamm, Robert S. Brown. Overt Hepatic Encephalopathy: Current Pharmacologic Treatments and Improving Clinical OutcomesThe American Journal of Medicine 2021; 134(11): 1330 doi: 10.1016/j.amjmed.2021.06.007
9
Yu Jun Wong, Jing Hong Loo. Albumin therapy for hepatic encephalopathy: current evidence and controversiesMetabolic Brain Disease 2022;  doi: 10.1007/s11011-022-01002-8